# Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study

> **NCT02099851** · NA · UNKNOWN · sponsor: **Noblewell** · enrollment: 6 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DEVICE:** Carotid body ablation (Cibiem)

## Key facts

- **NCT ID:** NCT02099851
- **Lead sponsor:** Noblewell
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099851, "Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02099851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*